Michael W. Washabaugh

Michael is a global leader for therapeutic protein & vaccine development with a broad span of influence and responsibility, involving novel products. He has previously held positions in Adello Biologics (CSO), MedImmunne (Senior Director, Research & Development), Merck & Co Inc. (Senior Director, Head of Biologics and Vaccine Analytical Science and has supported several launched products (US, EU & ROW) including eight vaccines, two monoclonal antibodies, two proteins and two drugs.